by rdbiomed | Nov 21, 2019 | Company News
RD Biomed is proud to announce that Peptest – a non-invasive device for diagnosing reflux disease – has been approved by Chinese health authorities and officially launched in China. The device, which detects the presence of pepsin (recognised as a diagnostic biomarker...
by rdbiomed | Nov 21, 2019 | Company News
Pancreatic lipase is important in dietary triacylglycerol breakdown: reducing pancreatic lipase activity reduces triacylglycerol breakdown resulting in lower amounts being absorbed by the body. In a collaborative project with the University of Newcastle, RD Biomed has...
by rdbiomed | Jun 26, 2019 | Company News
The RD Biomed team has been invited to attend Nanjing Tech Week in China – a fantastic opportunity to showcase our Peptest diagnostic technology to the Chinese government, medical innovators, healthcare specialists and potential partners. Hosted by the Nanjing...
by rdbiomed | Nov 12, 2017 | Company News
RD Biomed has achieved the highly-coveted ISO 13485: 2016 certification. ISO 13485 is an internationally agreed standard specific to the medical devices industry. Achieving this ISO certification indicates RD Biomed Limited meets the highest standards required of...
